CLINICAL DECISION SUPPORT SYSTEM FOR PARKINSON’S PATIENTS (Q2023893)
Jump to navigation
Jump to search
Project Q2023893 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CLINICAL DECISION SUPPORT SYSTEM FOR PARKINSON’S PATIENTS |
Project Q2023893 in Italy |
Statements
626,129.48 Euro
0 references
834,839.23 Euro
0 references
75.0 percent
0 references
31 October 2018
0 references
30 April 2020
0 references
MATE CONSULTING SRL
0 references
HOME MEDICINE SRL
0 references
UNIVERSITA' DEGLI STUDI DI SALERNO
0 references
RIATLAS SRL
0 references
40°40'49.30"N, 14°45'34.02"E
0 references
IL PROGETTO INTENDE SVILUPPARE, INDUSTRIALIZZARE E COMMERCIALIZZARE UN SISTEMA INTELLIGENTE DI SUPPORTO ALLE DECISIONI (CLINICAL DECISION SUPPORT SYSTEM) PER PAZIENTI CON DIAGNOSI DI PARKINSON.IL SISTEMA SI CARATTERIZZA PER L'UTILIZZO DI STRUMENTI AVANZATI DI ANALISI DI DATI, SFRUTTANDO LE POTENZIALITà DI INTELLIGENZA ARTIFICIALE, SECONDO IL PARADIGMA DELL'HEALTH KNOWLEDGE MANAGEMENT. GLI OBIETTIVI GENERALI DEL PROGETTO RIGUARDANO:- LA PRESA IN CARICO E CLASSIFICAZIONE AUTOMATICA DELLO STATO DI SALUTE DEL PAZIENTE CON PARKINSON, ADOTTANDO INDICI/SCALE UNIVERSALI DI CLASSIFICAZIONE, - LA CARATTERIZZAZIONE DI UN PROFILO METABOLOMICO DEI PAZIENTI CON PARKINSON, - LA PERSONALIZZAZIONE DI PERCORSI E/O PIANI DI FOLLOW-UP (CLINICO E RIABILITATIVO), BASATI SU MODELLI DI ANALISI DEI DATI PREDITTIVI, - IL MONITORAGGIO ATTIVO DEI PAZIENTI, DURANTE LA PROGRESSIONE DELLA MALATTIA, SECONDO SPECIFICI 'BIOMARCATORI' (ES. ICF, SIGNATURE METABOLOMICA).LO SCOPO Ê IL MIGLIORAMENTO DELL'APPROPRIATEZZA E (Italian)
0 references
THE AIM OF THE PROJECT IS TO DEVELOP, INDUSTRIALISE AND MARKET A SMART DECISION SUPPORT SYSTEM FOR PATIENTS WITH A DIAGNOSIS OF PARKINSON.THE SYSTEM IS CHARACTERISED BY THE USE OF ADVANCED TOOLS FOR DATA ANALYSIS, BUILDING ON THE IDEAS OF THE HEALTH KNOWLEDGE MANAGEMENT PARADIGM. THE GENERAL OBJECTIVES OF THE PROJECT RELATE TO THE AUTOMATIC TAKING AND CLASSIFICATION OF THE PATIENT’S HEALTH WITH PARKINSON, BY ADOPTING UNIVERSAL SCALES/SCALES OF CLASSIFICATION, — THE CHARACTERISATION OF A METABOLOMIC PROFILE OF PATIENTS WITH PARKINSON, — THE PERSONALISATION OF PATHWAYS AND/OR PLANS OF FOLLOW-UP (CLINICAL AND REHABILITATION), BASED ON MODELS FOR THE ANALYSIS OF PREDICTIVE DATA, — ACTIVE MONITORING OF PATIENTS DURING THE PROGRESSION OF THE DISEASE, ACCORDING TO SPECIFIC BIOMARKERS (ES). ICF, METABOLOMICS). (English)
0 references
LE PROJET VISE À DÉVELOPPER, À INDUSTRIALISER ET À COMMERCIALISER UN SYSTÈME INTELLIGENT D’AIDE À LA DÉCISION (SYSTÈME D’AIDE À LA DÉCISION CLINIQUE) POUR LES PATIENTS ATTEINTS DE PARKINSON DIAGNOSIS.LE SYSTÈME SE CARACTÉRISE PAR L’UTILISATION D’OUTILS AVANCÉS D’ANALYSE DE DONNÉES, EXPLOITANT LE POTENTIEL DE L’INTELLIGENCE ARTIFICIELLE, SELON LE PARADIGME DE LA GESTION DES CONNAISSANCES EN SANTÉ. LES OBJECTIFS GÉNÉRAUX DU PROJET SONT:- LA PRISE EN CHARGE ET LA CLASSIFICATION AUTOMATIQUE DE L’ÉTAT DE SANTÉ DU PATIENT AVEC PARKINSON, L’ADOPTION D’INDICES/ÉCHELLES DE CLASSIFICATION UNIVERSELLES, — LA CARACTÉRISATION D’UN PROFIL MÉTABOLOMIQUE DES PATIENTS DE PARKINSON, — LA PERSONNALISATION DES VOIES DE SUIVI ET/OU DES PLANS (CLINIQUES ET RÉHABILITANTS), SUR LA BASE DE MODÈLES D’ANALYSE DES DONNÉES PRÉDICTIVES, — LA SURVEILLANCE ACTIVE DES PATIENTS PENDANT LA PROGRESSION DE LA MALADIE, SELON DES «BIOMARQUEURS» SPÉCIFIQUES (E.G. ICF, SIGNATURE MÉTABOLOMIQUE).L’OBJECTIF EST D’AMÉLIORER LA PERTINENCE ET (French)
14 December 2021
0 references
Identifiers
B53D18000100007
0 references